IE34807B1 - Substituted naphthylalkylamines - Google Patents

Substituted naphthylalkylamines

Info

Publication number
IE34807B1
IE34807B1 IE1591/70A IE159170A IE34807B1 IE 34807 B1 IE34807 B1 IE 34807B1 IE 1591/70 A IE1591/70 A IE 1591/70A IE 159170 A IE159170 A IE 159170A IE 34807 B1 IE34807 B1 IE 34807B1
Authority
IE
Ireland
Prior art keywords
hydrogen
lower alkyl
naphthylalkylamines
substituted
hydroxyl
Prior art date
Application number
IE1591/70A
Other languages
English (en)
Other versions
IE34807L (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of IE34807L publication Critical patent/IE34807L/xx
Publication of IE34807B1 publication Critical patent/IE34807B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00Silicon; Compounds thereof
    • C01B33/113Silicon oxides; Hydrates thereof
    • C01B33/12Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/14Colloidal silica, e.g. dispersions, gels, sols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Amplifiers (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IE1591/70A 1969-12-12 1970-12-11 Substituted naphthylalkylamines IE34807B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1962497A DE1962497C3 (de) 1969-12-12 1969-12-12 Naphthylalkyl- a -hydroxyphenäthyl-amine, ihre Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
IE34807L IE34807L (en) 1971-06-12
IE34807B1 true IE34807B1 (en) 1975-08-20

Family

ID=5753745

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1591/70A IE34807B1 (en) 1969-12-12 1970-12-11 Substituted naphthylalkylamines

Country Status (25)

Country Link
US (1) US3966814A (US06262066-20010717-C00424.png)
JP (3) JPS5116420B1 (US06262066-20010717-C00424.png)
KR (2) KR780000007B1 (US06262066-20010717-C00424.png)
AR (2) AR194205A1 (US06262066-20010717-C00424.png)
AT (3) AT317192B (US06262066-20010717-C00424.png)
BE (1) BE760252A (US06262066-20010717-C00424.png)
BG (1) BG17956A3 (US06262066-20010717-C00424.png)
CH (1) CH556322A (US06262066-20010717-C00424.png)
CS (3) CS151062B2 (US06262066-20010717-C00424.png)
DE (1) DE1962497C3 (US06262066-20010717-C00424.png)
DK (1) DK136526B (US06262066-20010717-C00424.png)
ES (3) ES386345A1 (US06262066-20010717-C00424.png)
FI (1) FI53301C (US06262066-20010717-C00424.png)
FR (1) FR2081347B1 (US06262066-20010717-C00424.png)
GB (1) GB1330188A (US06262066-20010717-C00424.png)
HU (1) HU162736B (US06262066-20010717-C00424.png)
IE (1) IE34807B1 (US06262066-20010717-C00424.png)
IL (1) IL35840A (US06262066-20010717-C00424.png)
NL (1) NL169583C (US06262066-20010717-C00424.png)
NO (1) NO131126C (US06262066-20010717-C00424.png)
PL (3) PL84354B1 (US06262066-20010717-C00424.png)
RO (3) RO61132A (US06262066-20010717-C00424.png)
SE (1) SE378101B (US06262066-20010717-C00424.png)
SU (2) SU417936A3 (US06262066-20010717-C00424.png)
YU (3) YU35753B (US06262066-20010717-C00424.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2187319B1 (US06262066-20010717-C00424.png) * 1972-06-09 1975-06-20 Bottu Exploit Labo
AU501137B2 (en) * 1975-12-11 1979-06-14 Tanabe Seiyaku Co., Ltd. Benzyl alcohol derivatives
JPS53149940A (en) * 1977-06-02 1978-12-27 Tanabe Seiyaku Co Ltd Novel benzyl alcohol derivatives and their preparation
US4849453A (en) * 1983-01-31 1989-07-18 Eli Lilly And Company Growth promotion
US5250546A (en) * 1984-09-28 1993-10-05 Nippon Chemiphar Co., Ltd. Amino-alcohol derivatives and processes for their preparation
DE3880628T2 (de) * 1987-11-13 1993-08-05 Glaxo Group Ltd Phenethanolamin-derivate.
GB8809314D0 (en) * 1988-04-20 1988-05-25 Wellcome Found Anti-hypertensive sulfonanilides
US5194450A (en) * 1988-04-20 1993-03-16 Burroughs Wellcome Co. Anti-hypertensive sulfonanilides
US6329399B1 (en) * 1997-08-05 2001-12-11 Pola Chemical Industries, Inc. Antifungal amine derivatives and processing for producing the same
NZ549535A (en) 2004-03-17 2010-11-26 Novartis Ag Use of aliskiren for treating renal and other disorders
AU2013202127B2 (en) * 2006-08-10 2014-06-12 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (R,R-)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure
WO2008022038A1 (en) * 2006-08-10 2008-02-21 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
EP2544676B1 (en) 2010-03-10 2018-09-19 The United States of America, as represented by The Secretary, Department of Health and Human Services The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
JP6208031B2 (ja) * 2014-01-30 2017-10-04 東芝ライフスタイル株式会社 ブラシレスモータおよびその製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE894396C (de) * 1944-05-21 1953-10-26 Troponwerke Dinklage & Co Verfahren zur Herstellung von 1-(o-, m- oder p-Oxyphenyl)-1-oxy-2-aralkylamino-aethanen
US3135797A (en) * 1958-04-15 1964-06-02 Colgate Palmolive Co Aromatic amino antispasmodic compounds
US3139441A (en) * 1960-02-16 1964-06-30 Colgate Palmolive Co Alpha (3, 4 dihidroxy phenyl)-beta-(nu-3, 14'-methylenedioxy-phenyl)-alkylamino ethanols
NL125650C (US06262066-20010717-C00424.png) * 1962-11-30 1900-01-01
GB1059968A (en) * 1964-01-20 1967-02-22 Ici Ltd Naphthalene derivatives
NL6401871A (US06262066-20010717-C00424.png) * 1964-02-27 1965-08-30
GB1095378A (US06262066-20010717-C00424.png) * 1965-06-22
DE1543372A1 (de) * 1966-10-18 1971-04-01 Boehringer Sohn Ingelheim Verfahren zur Herstellung von o-substituierten 3,4-Dioxyphenylalkanolaminen

Also Published As

Publication number Publication date
AR194205A1 (es) 1973-06-29
BE760252A (fr) 1971-06-11
JPS5221505B1 (US06262066-20010717-C00424.png) 1977-06-10
US3966814A (en) 1976-06-29
SU505349A3 (ru) 1976-02-28
IL35840A (en) 1974-06-30
CS151062B2 (US06262066-20010717-C00424.png) 1973-09-17
GB1330188A (en) 1973-09-12
NL7018031A (US06262066-20010717-C00424.png) 1971-06-15
SE378101B (US06262066-20010717-C00424.png) 1975-08-18
NO131126B (US06262066-20010717-C00424.png) 1974-12-30
YU35753B (en) 1981-06-30
CS151063B2 (US06262066-20010717-C00424.png) 1973-09-17
ES386345A1 (es) 1974-01-01
AT302284B (de) 1972-10-10
FR2081347B1 (US06262066-20010717-C00424.png) 1974-08-30
AT317192B (de) 1974-08-12
ES395481A1 (es) 1973-12-16
IL35840A0 (en) 1971-02-25
SU384229A3 (US06262066-20010717-C00424.png) 1973-05-23
DE1962497A1 (de) 1971-06-16
RO61063A (fr) 1978-07-15
JPS5116420B1 (US06262066-20010717-C00424.png) 1976-05-24
YU137878A (en) 1981-02-28
PL84355B1 (US06262066-20010717-C00424.png) 1976-03-31
YU137978A (en) 1981-02-28
AR198224A1 (es) 1974-06-07
NL169583C (nl) 1982-08-02
FI53301B (US06262066-20010717-C00424.png) 1977-12-30
KR780000007B1 (en) 1978-03-04
YU35868B (en) 1981-08-31
RO56808A (US06262066-20010717-C00424.png) 1975-03-15
ES395482A1 (es) 1973-12-16
HU162736B (US06262066-20010717-C00424.png) 1973-04-28
PL81424B1 (US06262066-20010717-C00424.png) 1975-08-30
DE1962497B2 (de) 1979-01-25
BG17956A3 (US06262066-20010717-C00424.png) 1974-03-05
SU417936A3 (US06262066-20010717-C00424.png) 1974-02-28
DK136526B (da) 1977-10-24
RO61132A (US06262066-20010717-C00424.png) 1976-12-15
CS151064B2 (US06262066-20010717-C00424.png) 1973-09-17
FR2081347A1 (US06262066-20010717-C00424.png) 1971-12-03
NL169583B (nl) 1982-03-01
KR780000269B1 (en) 1978-07-24
YU301070A (en) 1980-12-31
AT299924B (de) 1972-07-10
PL84354B1 (US06262066-20010717-C00424.png) 1976-03-31
IE34807L (en) 1971-06-12
YU35867B (en) 1981-08-31
FI53301C (fi) 1978-04-10
DK136526C (US06262066-20010717-C00424.png) 1978-03-28
NO131126C (US06262066-20010717-C00424.png) 1975-04-09
JPS5138716B1 (US06262066-20010717-C00424.png) 1976-10-23
CH556322A (de) 1974-11-29
DE1962497C3 (de) 1979-09-20

Similar Documents

Publication Publication Date Title
IE42216L (en) Benzomorphane derivatives
ES8202546A1 (es) Metodo de producir derivados de tiazolidina
IE34807B1 (en) Substituted naphthylalkylamines
IE40392B1 (en) Pyrimidine derivatives, process for their preparation and their use in pharmaceutical compositions
IE41528L (en) Furfuryl-benzomorphane derivatives.
IE822410L (en) Substituted azetidinols
IE40511L (en) Pyridyl piperidine derivatives
ES431514A1 (es) Procedimiento para la preparacion de 2 - (heteroaril-metil)-5,9 beta - dialcohil-6,7-benzomorfanos.
IE36326L (en) Diamines
IE45674L (en) Isoquinolines and benzazepines.
IE45700L (en) PYRAZOLO (3,4-b) PYRIDINES
ES470787A1 (es) Procedimiento para preparar derivados de benzoquinolicina
IE41440L (en) Thiatetracyclines
IE38096L (en) Pharmaceutically active phenylpropionic acid preparations
IE41244B1 (en) Pyridobenzodiazepinones
ES425015A1 (es) Procedimiento para la preparacion de n-(heteroaril-metil)- 6,14-endoeteno-7alfa-hidroxialcohil - tetrahidro - nororipa-vinas y tebainas.
ES424310A1 (es) Procedimiento para la preparacion de n-(heteroarilmetil)-7 acil-6,14-endoetenotetrahidronororipavinas y -tebai nas.
IE45672L (en) Substituted aminoalkyl phthalazinones and quinazolinones
IE45258L (en) Tetrahydronaphthalenes
ES449446A1 (es) Un procedimiento para la produccion de acidos 1-oxo-1h-6-pi-peridinogicamente activos y esteres de los mismos.
IE40722L (en) Indolopiperidino -alkylphenothiazines
IE42048L (en) Dienylphosphates and 1, 4-cycloadducts.
IE780742L (en) Isoxazolylmethyl-benzomorphanes
IE35788L (en) 1, 5-benzodiazepinones.
IE40082L (en) Pyrazolo-pyrimidine derivatives; insecticides